ArticlePharmacoEconomics2020
Cost Effectiveness of Teplizumab for Prevention of Type 1 Diabetes Among Different Target Patient Groups.
Shweta Mital et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticlePharmacoEconomics2020
Shweta Mital et al.PubMed ↗Publisher ↗
No numbers read from the abstract.